title: The prrAB two-component system is essential for Mycobacterium tuberculosis viability and is induced under nitrogen-limiting conditions.
abstract: The Mycobacterium tuberculosis prrA-prrB (Rv0903c-Rv0902c) two-component regulatory system is expressed during intracellular growth in human macrophages and is required for early intracellular multiplication in murine macrophages, suggesting its importance in establishing infection. To better understand the function of the prrA-prrB two-component system, we defined the transcriptional characteristics of the prrA and prrB genes during exponential and stationary growth and upon exposure to different environmental stresses and attempted to generate a prrA-prrB deletion mutant. The prrA and prrB genes constitute an operon and are cotranscribed during logarithmic growth, with transcriptional levels decreasing in stationary phase and during hypoxia. Despite the transcriptional differences, PrrA protein levels remained relatively stable throughout growth and in hypoxia. Under conditions of nitrogen limitation, prrAB transcription was induced, while acidic pH stress and carbon starvation did not significantly alter transcript levels. Deletion of the prrAB operon on the chromosome of M. tuberculosis H37Rv occurred only in the presence of an episomal copy of the prrAB genes, indicating that this two-component system is essential for viability. Characterization of the prrAB locus in M. tuberculosis Mt21D3, a previously described prrA transposon mutant, revealed that this strain is not a true prrA knockout mutant. Rather, Tn5367 transposon insertion into the prrA promoter only decreased prrA and prrB transcription and PrrA levels in Mt21D3 compared to those in the parental Mt103 clinical strain. These data provide the first report describing the essentiality of the M. tuberculosis prrAB two-component system and reveal insights into its potential role in mycobacterial growth and metabolism.
authors.affiliation: The Biodesign Institute Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA. shelley.haydel@asu.edu
authors.forename: Shelley E
authors.initials: SE
authors.lastname: Haydel
authors.forename: Vandana
authors.initials: V
authors.lastname: Malhotra
authors.forename: Garrett L
authors.initials: GL
authors.lastname: Cornelison
authors.forename: Josephine E
authors.initials: JE
authors.lastname: Clark-Curtiss
mesh_terms: D001426:Bacterial Proteins / Q000378:metabolism*; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000254:growth & development / Q000378:metabolism* / Q000472:pathogenicity; D009584:Nitrogen / Q000378:metabolism* / Q000494:pharmacology*; D009876:Operon; D010101:Oxygen Consumption; D015398:Signal Transduction; D014158:Transcription, Genetic; D014774:Virulence
chemical_list: D001426:Bacterial Proteins; D009584:Nitrogen
references.citation: Mol Microbiol. 2003 Apr;48(1):77-84
references.pmid: 12657046
references.citation: FEMS Microbiol Lett. 2004 Jul 15;236(2):341-7
references.pmid: 15251217
references.citation: Trends Biochem Sci. 2007 May;32(5):225-34
references.pmid: 17433693
references.citation: Mol Microbiol. 2001 Jul;41(1):179-87
references.pmid: 11454210
references.citation: Microbiology (Reading). 2004 Jan;150(Pt 1):241-246
references.pmid: 14702417
references.citation: Microb Pathog. 1999 Apr;26(4):195-206
references.pmid: 10089160
references.citation: Microb Pathog. 2008 Jan;44(1):71-7
references.pmid: 17888619
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12706-11
references.pmid: 11675502
references.citation: Infect Immun. 2003 Dec;71(12):6962-70
references.pmid: 14638785
references.citation: Infect Immun. 2003 Jul;71(7):3927-36
references.pmid: 12819079
references.citation: Tuberculosis (Edinb). 2009 Mar;89(2):169-74
references.pmid: 19217827
references.citation: Microbiology (Reading). 2002 Oct;148(Pt 10):3007-3017
references.pmid: 12368434
references.citation: Mol Microbiol. 2002 Feb;43(3):717-31
references.pmid: 11929527
references.citation: Infect Immun. 2002 May;70(5):2256-63
references.pmid: 11953357
references.citation: J Biol Chem. 2006 Apr 7;281(14):9659-66
references.pmid: 16434396
references.citation: Mol Microbiol. 2006 May;60(3):643-57
references.pmid: 16629667
references.citation: Microbiology (Reading). 2004 Apr;150(Pt 4):865-875
references.pmid: 15073296
references.citation: Appl Environ Microbiol. 2007 Aug;73(15):4839-48
references.pmid: 17545328
references.citation: Nature. 1991 Jun 6;351(6326):456-60
references.pmid: 1904554
references.citation: FEMS Microbiol Lett. 2004 Feb 16;231(2):237-45
references.pmid: 14987770
references.citation: J Biol Chem. 2010 Oct 15;285(42):32325-35
references.pmid: 20702407
references.citation: J Exp Med. 1999 May 3;189(9):1425-36
references.pmid: 10224282
references.citation: Infect Immun. 2009 Mar;77(3):1230-7
references.pmid: 19103767
references.citation: J Bacteriol. 2008 Nov;190(21):7108-16
references.pmid: 18689485
references.citation: Biochemistry. 2007 Jun 12;46(23):6733-43
references.pmid: 17511470
references.citation: Biochemistry. 1969 Jun;8(6):2681-5
references.pmid: 5799144
references.citation: J Bacteriol. 2006 Jan;188(1):150-9
references.pmid: 16352831
references.citation: J Bacteriol. 2000 Jul;182(13):3832-8
references.pmid: 10851001
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11554-9
references.pmid: 10500215
references.citation: Pharmaceuticals (Basel). 2010 Jul 1;3(7):2268-2290
references.pmid: 21170297